AXS is sitting at an interesting point in its long-term monthly structure.
After the massive 2021 expansion and the multi-year correction that followed, price has now compressed into a much smaller range around $1–$2.
The current structure gives me two main paths.
Path 1: Price breaks higher from the current range and expands toward the $4.50–$5.00 target area. From there, a retracement toward the $2.90 liquidity zone could precede another expansion.
Path 2: Price fails to sustain the current recovery, sweeps lower first and moves toward the $0.26–$0.35 area before the larger cycle expansion begins.
Follow, Boost, Join, Thank You!
Financial Disclaimer: This post is not financial advice. I am not your financial advisor, your life coach, or your legally responsible adult. Always do your own research and never trade based solely on internet content.
After the massive 2021 expansion and the multi-year correction that followed, price has now compressed into a much smaller range around $1–$2.
The current structure gives me two main paths.
Path 1: Price breaks higher from the current range and expands toward the $4.50–$5.00 target area. From there, a retracement toward the $2.90 liquidity zone could precede another expansion.
Path 2: Price fails to sustain the current recovery, sweeps lower first and moves toward the $0.26–$0.35 area before the larger cycle expansion begins.
Follow, Boost, Join, Thank You!
Financial Disclaimer: This post is not financial advice. I am not your financial advisor, your life coach, or your legally responsible adult. Always do your own research and never trade based solely on internet content.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.